DAVA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Endava PLC (DAVA) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock's technical indicators are bearish, financial performance is weak, and there are no significant positive catalysts or trading signals to justify an immediate purchase. Holding off for now is the best course of action.
The technical indicators for DAVA are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 45.189, and the moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The current price is below the pivot level of 5.015, with support at 4.492 and resistance at 5.539. Overall, the stock shows no clear upward momentum.
NULL. There are no recent news updates, no positive trading trends from hedge funds or insiders, and no recent congress trading data. Analysts acknowledge healthy free cash flow but expect incremental improvements to take time.
The company's financial performance in Q2 2026 is weak, with revenue down 5.88% YoY, net income dropping by 200.80% YoY, and EPS declining by 218.18% YoY. Gross margin also fell by 11.29%. Analysts have lowered price targets, and the stock's technical indicators suggest bearish momentum.
In Q2 2026, Endava PLC reported a revenue decline of 5.88% YoY to $184.1 million. Net income dropped significantly to -$6.91 million, a decline of 200.80% YoY. EPS fell by 218.18% YoY to -$0.13. Gross margin decreased to 20.42%, down 11.29% YoY. These results indicate weak financial performance.
Analysts have recently lowered their price targets for DAVA. TD Cowen reduced the target to $6.50 from $8, JPMorgan lowered it to $9 from $10, and Guggenheim reduced it to $13 from $15. While Guggenheim maintains a Buy rating, other firms have Neutral or Hold ratings, reflecting mixed sentiment. Analysts expect some improvement in FY26 guidance but note challenges from FX and investments.
